{"id":497561,"date":"2026-06-13T09:27:08","date_gmt":"2026-06-13T09:27:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/497561\/"},"modified":"2026-06-13T09:27:08","modified_gmt":"2026-06-13T09:27:08","slug":"mrna-therapy-shows-potential-to-reprogram-allergic-responses","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/497561\/","title":{"rendered":"mRNA Therapy Shows Potential to Reprogram Allergic Responses"},"content":{"rendered":"<p data-start=\"419\" data-end=\"660\">A novel combination of mRNA technology and immune modulation may offer a new strategy for treating allergic diseases, according to new research demonstrating enhanced immune tolerance and reduced allergic inflammation in a preclinical model.<\/p>\n<p>Moving Beyond Symptom Control<\/p>\n<p data-start=\"699\" data-end=\"904\">Current allergy treatments often focus on managing symptoms or reducing exposure to triggers. However, researchers are increasingly exploring ways to retrain the immune system itself to tolerate allergens.<\/p>\n<p data-start=\"906\" data-end=\"1224\">In the new study, investigators tested an allergen-specific messenger RNA-lipid nanoparticle (mRNA-LNP) therapy designed to alter immune responses to allergens. The approach was evaluated alone and in combination with an inhibitor of the mechanistic target of rapamycin (mTOR), a key regulator of immune cell function.<\/p>\n<p>Promoting Immune Tolerance<\/p>\n<p data-start=\"1260\" data-end=\"1475\">The mRNA-LNP vaccine alone stimulated immune pathways associated with protection against allergic disease, including T helper 1 and cytotoxic T-cell responses that counterbalance allergy-driving T helper 2 activity.<\/p>\n<p data-start=\"1477\" data-end=\"1762\">When combined with mTOR inhibition, however, the immune response shifted further toward tolerance. Researchers observed a substantial increase in functional regulatory T cells (Tregs), which play a critical role in suppressing excessive immune reactions and maintaining immune balance.<\/p>\n<p>Reduced Signs of Allergic Asthma<\/p>\n<p data-start=\"1804\" data-end=\"2009\">In a mouse model of allergic asthma, the combination strategy maintained the anti-allergic benefits of the mRNA therapy while reducing markers of eosinophil activation, a hallmark of allergic inflammation.<\/p>\n<p data-start=\"2011\" data-end=\"2110\">The treatment also limited airway inflammation and other features associated with allergic disease.<\/p>\n<p>Potential Safety Advantages<\/p>\n<p data-start=\"2147\" data-end=\"2371\">An additional benefit was a reduction in vaccine-associated cytotoxicity. The combination approach dampened some of the inflammatory immune responses seen with mRNA-LNP therapy alone while preserving its therapeutic effects.<\/p>\n<p data-start=\"2373\" data-end=\"2492\">This suggests that mTOR inhibition may help fine-tune immune responses, potentially improving both efficacy and safety.<\/p>\n<p>A New Frontier for Allergy Treatment<\/p>\n<p data-start=\"2538\" data-end=\"2826\">The findings highlight the growing potential of mRNA-based therapies beyond infectious diseases. By promoting allergen-specific immune tolerance rather than simply suppressing symptoms, the approach could represent a new direction in the treatment of asthma and other allergic conditions.<\/p>\n<p data-start=\"2828\" data-end=\"3064\" data-is-last-node=\"\" data-is-only-node=\"\">While the results are currently limited to preclinical studies, the researchers believe that combining mRNA therapies with immune-regulating strategies could eventually provide more durable control of allergic and inflammatory diseases.<\/p>\n<p data-start=\"2828\" data-end=\"3064\" data-is-last-node=\"\" data-is-only-node=\"\">Reference<\/p>\n<p data-start=\"2828\" data-end=\"3064\" data-is-last-node=\"\" data-is-only-node=\"\">Rochman Y et al. Antigen-Specific mRNA\u2013LNP Therapy with mTOR Inhibition Promotes Treg Cells and Limits Allergy. Journal of Allergy and Clinical Immunology. 2026;DOI:10.1016\/j.jaci.2026.05.023.<\/p>\n","protected":false},"excerpt":{"rendered":"A novel combination of mRNA technology and immune modulation may offer a new strategy for treating allergic diseases,&hellip;\n","protected":false},"author":2,"featured_media":497562,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[103,61,60],"class_list":["post-497561","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-ie","tag-ireland"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/497561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=497561"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/497561\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/497562"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=497561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=497561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=497561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}